Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2005
10/12/2005EP1583545A2 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
10/12/2005EP1583543A2 Methods and therapeutic compositions in the treatment of advanced cancer
10/12/2005EP1583526A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1583500A2 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
10/12/2005EP1494659B1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/12/2005EP1335747A4 A composition of sodium channel blocking compound
10/12/2005EP1313467B1 Novel pharmaceutical composition for administering n-0923
10/12/2005EP1259814B1 Bcmp-7 as marker for diagnosis of breast cancer
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1185249B1 Use of a biodegradable polymer
10/12/2005EP1140033B1 Improved controlled release compositions
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP1049793B1 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/12/2005EP0975791B1 Marine bacterial strain of the genus vibrio, water-soluble polysaccharides produced by said strain and their uses
10/12/2005EP0842435B1 Stabilized aqueous steroid immunoassay standards with cyclodextrins
10/12/2005EP0814842B1 Method for treating amyloidosis
10/12/2005EP0760240B1 Composition for stimulating the cerebral activity comprising vinpocetine citrate and a plant extract comprising xanthines
10/12/2005CN1682390A Method for manufacture of films containing insoluble solids embedded in cellulose-based films
10/12/2005CN1681846A Process for producing hydroxyalkyl starch derivatives
10/12/2005CN1681845A Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
10/12/2005CN1681844A Hasylated polypeptides, especially hasylated erythropoietin
10/12/2005CN1681836A Targeting proteins to deliver therapeutic or diagnostic reagents
10/12/2005CN1681535A Hydroxyalkyl amidon-allergen compositions
10/12/2005CN1681534A Drug absorbability improving agents
10/12/2005CN1681528A Use of urease for inhibiting cancer cell growth
10/12/2005CN1681527A Therapies for renal failure using interferon-beta
10/12/2005CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
10/12/2005CN1681509A Slow release preparation containing larmotriazine
10/12/2005CN1681483A Improved oral microcapsule with low-solubility active component
10/12/2005CN1681386A Compositions and products containing s-equol, and methods for their making
10/12/2005CN1680449A Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol
10/12/2005CN1680448A Macrogol-interferon, preparation and use thereof
10/12/2005CN1680443A Recombinat protein containing albumin multimer
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1679963A Coupling agent of CB and specific immune globulin IgG and use thereof
10/12/2005CN1679962A Pharmaceutical compositions
10/12/2005CN1679961A Cytomembrane imitated polymer micella as medicine carrying system
10/12/2005CN1679960A Carrier of regulating medicine releasing speed and preparation thereof
10/12/2005CN1679959A Liver targeted auxiliary material containing D-glactose and sterol and its use
10/12/2005CN1679958A Implants for administering substances and methods of producing implants
10/12/2005CN1679957A A pharmaceutical composition containing liposomes for treating a cancer
10/12/2005CN1679938A Pharmaceutical compositions
10/12/2005CN1679937A Compositions and methods for treating or preventing inflammatory diseases
10/12/2005CN1679932A Ordered molecular presentation of antigens, method of preparation and use
10/12/2005CN1679925A Sustained releasing microspheric preparation of glucokinase mutant and its making method
10/12/2005CN1679917A Oil-free pharmaceutical compositions containing cyclosporin A
10/12/2005CN1679916A Pharmaceutical compositions
10/12/2005CN1679827A Method for making substrate for paste from Chinese prickly ash and oral medicinal materials
10/12/2005CN1679584A Medicine for treating osteomyelitis and preparation thereof
10/12/2005CN1679583A Pharmaceutical composition comprising condensed indole compound
10/12/2005CN1679581A Composition of an external dermatological agent and fibers with effect of promoting lipid decomposition
10/12/2005CN1679569A Stable extended release oral dosage composition
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679543A Medicine containing active components of methylcantharidimide and its preparing method and use
10/12/2005CN1679522A Composition of an external dermatological agent
10/12/2005CN1679517A Thin-membrane coating material of enteric coated water soluble medicine and preparation thereof
10/12/2005CN1679515A Slow-releasing polymer microglobe of analgesic and preparation thereof
10/12/2005CN1679512A Stable injection composition and method therefor
10/12/2005CN1679472A Antimycotic nail varnish composition
10/12/2005CN1222321C Pharmaceutical compositions containing cyclodextrins and taxoids
10/12/2005CN1222320C Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof
10/12/2005CN1222319C Composition for IVF
10/12/2005CN1222318C Cellulosic particle for pharmaceutical preparation
10/12/2005CN1222317C Quickly disintegrable compression-molded materials and process for producing the same
10/12/2005CN1222316C Oral liquor composition with reduced bitter taste
10/12/2005CN1222315C Stable liquid interferon formulations
10/12/2005CN1222312C Fibrin ferment hemostatic suppository
10/12/2005CN1222309C Transfer of molecules into cytosol of cells
10/12/2005CN1222292C Fulvestrant formulation
10/12/2005CN1222290C Novel composition and use thereof
10/12/2005CN1222287C Pharmaceutical formulations contg. zolmitriptan
10/12/2005CN1222284C High lipid diet
10/12/2005CN1222281C Patches for external use
10/12/2005CN1222280C Topical plaster with non-steroidal antirheumatic agents with an acid group
10/12/2005CN1222279C Prolonged release bioadhesive vaginal gel dosage form
10/12/2005CN1222277C Microgranules based on active principle and method for making same
10/12/2005CN1222275C Nano emulsion based on sugar fatty ester and sugar fatty ether, and use thereof
10/12/2005CN1222274C Expandable gastroretentive therapeutic system with prolonged stomach retention time
10/11/2005US6953840 Methods of using non-human animal Apolipoprotein A-I protein
10/11/2005US6953784 Cross-linked polysaccharide drug carrier
10/11/2005US6953776 Ophthalmic formulations
10/11/2005US6953675 Landscaped antibodies and antibody fragments for clinical use
10/11/2005US6953625 Heparin-polyoxyalkylenepolyamine adducts, and methods of making and using such adducts are disclosed. Compositions including a quaternary ammonium heparin complex, a moisture curable polysiloxane, and an organic solvent are also
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953575 Methods of treating central nervous system disorders using viral vectors
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005CA2358773C Improved controlled release compositions and method
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2315818C Water-soluble eye drop
10/11/2005CA2167921C Biodegradable particles
10/07/2005CA2504404A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/06/2005WO2005093422A2 Carbohydrate-encapsulated quantum dots for biological imaging
10/06/2005WO2005093048A1 Cancerous disease modifying antibodies
10/06/2005WO2005092989A1 Particle-stabilised emulsions
10/06/2005WO2005092929A1 Hyaluronic acid butyric esters with a low degree of substitution, procedure for their preparation and use
10/06/2005WO2005092928A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
1 ... 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 ... 1712